| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 06/08/2006 | US20060122245 Novel inhibitors of IMPDH enzyme |
| 06/08/2006 | US20060122223 Substituted amino carboxylic acids |
| 06/08/2006 | US20060122193 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 06/08/2006 | US20060122183 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 06/08/2006 | US20060122125 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof |
| 06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
| 06/08/2006 | CA2589010A1 Biaryloxymethylarene carboxylic acids |
| 06/08/2006 | CA2583335A1 1-alkynyl-2-aryloxyalkylamides and their use as fungicides |
| 06/07/2006 | EP1666475A1 Elektronenakzeptoren für Polymere Dünnschicht-Wellenleitermedien |
| 06/07/2006 | EP1666035A1 Medicinal composition for treatment for fatty liver or liver disease |
| 06/07/2006 | EP1664014A2 Process for the asymmetric hydrogenation of beta-amino ketones |
| 06/07/2006 | EP1664012A1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
| 06/07/2006 | EP1664011A2 Ophthalmic compositions for treating ocular hypertension |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663959A1 Novel amidine compounds for treating microbial infections |
| 06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
| 06/07/2006 | EP1663936A1 Biaryloxymethylarene-carboxylic acids |
| 06/07/2006 | EP1663934A1 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds |
| 06/07/2006 | EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1572354B1 Supported catalyst containing rhenium and method for hydrogenation of carbonyl compounds in liquid phase by means of said catalyst |
| 06/07/2006 | EP1558597A4 Continuous process for the production of optically pure (s)-beta hydroxy-gamma-butyrolactone |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 06/07/2006 | CN1784381A Method for crystallizing guanidinium salts |
| 06/07/2006 | CN1784380A Novel bioisosteres of actinonin |
| 06/07/2006 | CN1784235A Fortifier |
| 06/07/2006 | CN1781922A Camptothecine derivative, preparing method and use |
| 06/07/2006 | CN1258530C Crystalline base of citalopram |
| 06/07/2006 | CN1258514C Method of preparing cyclopropane carboxylic acid and its intermediate |
| 06/07/2006 | CN1258508C Aldehyde acetal preparation method |
| 06/06/2006 | US7057055 Process for preparing a deuterated or tritiated compound |
| 06/06/2006 | US7057054 Hexafluorocyclopentene di-substituted with an alkoxy- and aryl-substituted furan and/or thiophene; e.g., 1,2-bis(2-methoxy-5-phenyl-3-thienyl)hexafluorocyclopentene; nonfading |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/06/2006 | US7056894 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/06/2006 | CA2232913C Process for the preparation of azide derivatives |
| 06/06/2006 | CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/06/2006 | CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006057261A1 Processes for producing 5-phthalancarbonitrile and citalopram |
| 06/01/2006 | WO2006056591A1 A process for the dimerisation of levulinic acid, dimers obtainable by such process and esters of such dimers |
| 06/01/2006 | WO2005034940A8 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 06/01/2006 | US20060116522 Process for the preparation of 5-substituted-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| 06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
| 06/01/2006 | US20060116418 Materials and methods for treating hypercholesterolemia |
| 06/01/2006 | US20060116398 E.g., biphenyl-2-ylcarbamic acid 1-{9-[2-(4-hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)ethylamino]nonyl}piperidin-4-yl ester;respiratory system disorders; bronchodilators; chronic obstructive pulmonary disease or asthma; affinity for dopamine D2 receptors; used with phosphodiesterase-4 inhibitor |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | US20060116374 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | US20060115516 Copolymerizable methine and anthraquinone compounds and articles containing them |
| 06/01/2006 | DE102004056820A1 Preparation of dihydroindene derivatives comprises reacting benzene compounds with indene compounds in the presence of catalyst system containing e.g. ligand and a solvent system containing two solvents from e.g. tertiary amine and alcohol |
| 06/01/2006 | DE102004056626A1 Substituierte Oxyguanidine Substituted oxyguanidines |
| 06/01/2006 | CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660859A2 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 05/31/2006 | EP1660459A2 Arylsulfonamidobenzylic compounds |
| 05/31/2006 | EP1660440A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 05/31/2006 | EP1660436A1 Cathepsin inhibitors |
| 05/31/2006 | EP1660428A1 Ppar modulators |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1659881A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 05/31/2006 | EP1448181B1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 05/31/2006 | EP1315500A4 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | EP1251822A4 Novel coupler for use in oxidative hair dyeing |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1780828A Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives |
| 05/31/2006 | CN1780825A Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 05/31/2006 | CN1780818A Derivados c¿¼clicos fenil-substitu¿¼dos |
| 05/31/2006 | CN1780619A Derivados de benzoxazol e benzotiazol substitu¿¼dos com (dialopropenil)fenilalquila pesticidas |
| 05/31/2006 | CN1778799A Fast production of high-purity radix ligustici sinensis lactone |
| 05/31/2006 | CN1257907C Ginkgo lactone compound and its preparation and medicinal composition containing it |
| 05/31/2006 | CN1257906C Preparation process of isosorbide mononitrate |
| 05/31/2006 | CN1257898C 4-phenylacetylene benzoic anhydride preparation method |
| 05/31/2006 | CN1257897C Method of preparing gamma butyrolactone by 1,4-butanediol dehydrogenation |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7053225 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6) deca-3,8-diene; for Diels-Alder reaction; antitumor agents |
| 05/30/2006 | US7053224 Intermediates and improved processes for the preparation of neplanocin A |
| 05/30/2006 | US7053221 Heteroatom-stabilized carbenes and precursors thereto as depolymerization catalysts |
| 05/30/2006 | US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect |
| 05/30/2006 | US7053118 Therapeutic treatment of cancer, tumor with plakolide A, an alpha -exomethylene- gamma -disubstituted- gamma -lactone; an extracts of marine sponges of the family Plakinidae; stereospecfic |
| 05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/30/2006 | US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7052885 Process for preparing heterocyclic (R)- and (S)-cyanohydrins |
| 05/30/2006 | US7052742 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/30/2006 | CA2065128C Process for the preparation of phosphorus-containing l-amino acids, their derivatives and intermediates for this process |
| 05/26/2006 | WO2006055725A2 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 05/26/2006 | WO2006055625A2 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors |
| 05/26/2006 | WO2006054793A1 Benzofuran compound and pharmaceutical composition containing the same |
| 05/26/2006 | WO2006053748A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |